The purpose of SMA Europe is to provide a framework to stimulate collaboration and accelerate translational research pathways in SMA and promote patient care.

  1. EMA workshop on SMA to be broadcasted live

    EMA workshopThe EMA workshop on SMA, co-organised by the European Medicines Agency (EMA), SMA Europe and TREAT NMD which will take place next Friday, 11th November, will be broadcasted. To find out how to view the broadcast, please see the EMA website for instructions.

    The EMA workshop will bring together key stakeholders to discuss, help and advance the development of therapies for the treatment of SMA. Topics for discussion will include an overview of the disease, the pharmacology of the molecules under investigation, natural history data, clinical outcome measures and biomarkers.